Show simple item record

dc.contributor.authorSantacruz J.C
dc.contributor.authorMantilla M.J
dc.contributor.authorRodríguez-Salas G
dc.contributor.authorRueda I
dc.contributor.authorMaría Santos A
dc.contributor.authorLondoño J.
dc.date.accessioned2024-11-01T14:34:48Z
dc.date.available2024-11-01T14:34:48Z
dc.date.issued2024
dc.identifier.issn1218123
dc.identifier.otherhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85146567810&doi=10.1016%2fj.rcreu.2022.10.004&partnerID=40&md5=c3e283effd88b5e3bf17ce2830d4c099
dc.identifier.urihttp://hdl.handle.net/10818/62212
dc.description.abstractInterstitial lung disease in lupus is an entity that occurs infrequently and tends to progress slowly in most cases. Despite this, the therapeutic approach for moderate to severe cases is largely unknown because most of the evidence comes from case reports, many of which predate the advent of today's known treatments for lupus. Additionally, little progress has been made in understanding its pathophysiology and current concepts come from other connective tissue diseases such as systemic sclerosis or are grouped within the group of interstitial pneumonias with autoimmune characteristics. This, to an extent, has been an obstacle for research in this field, and to date there is no unified diagnostic and therapeutic approach. Therefore we conducted a state of the art search of the best evidence available to date, in terms of diagnostic methods and emerging therapies, to offer the clinician a practical vision for a comprehensive approach. © 2022 Asociación Colombiana de Reumatologíaen
dc.formatapplication/pdfes_CO
dc.language.isoenges_CO
dc.publisherRevista Colombiana de Reumatologiaes_CO
dc.relation.ispartofseriesRevista Colombiana de Reumatologia Vol. 31 N° 2
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceUniversidad de La Sabanaes_CO
dc.sourceIntellectum Repositorio Universidad de La Sabanaes_CO
dc.subject.otherGlucocorticoiden
dc.subject.otherNintedaniben
dc.subject.otherClinical practiceen
dc.subject.otherClinicianen
dc.subject.otherConnective tissue diseaseen
dc.subject.otherDiagnostic Procedureen
dc.subject.otherHumanen
dc.subject.otherInterstitial lung diseaseen
dc.subject.otherInterstitial pneumoniaen
dc.titleInterstitial lung disease in systemic lupus erythematosus: state of the art searchen
dc.typejournal articlees_CO
dc.type.hasVersionpublishedVersiones_CO
dc.rights.accessRightsopenAccesses_CO
dc.identifier.doi10.1016/j.rcreu.2022.10.004


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 InternationalExcept where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International